Hypoaldosteronism risk factors
|
Hypoaldosteronism Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hypoaldosteronism risk factors On the Web |
|
American Roentgen Ray Society Images of Hypoaldosteronism risk factors |
|
Risk calculators and risk factors for Hypoaldosteronism risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
==Overview==[1]
Common risk factors in the development of hypoaldosteronism include diabetes mellitus, sickle cell anemia, HIV, graves' disease, [risk factor 3], and [risk factor 4].
Risk Factors
- Common risk factors in the development of [disease name] include Diabetes mellitus, [risk factor 2], [risk factor 3], and [risk factor 4].
===Common Risk Factors===[2][3]
- Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral.
- Common risk factors in the development of [disease name] include:
- Diabetes mellitus
- Sicke cell anemia
- HIV
- Graves' disease
- Hypoparathyroidism
- Hypopituitarism
- Myasthenia gravis
- Pernicious anemia
Less Common Risk Factors
- Less common risk factors in the development of [disease name] include:[4]
- Multiple myeloma
- SLE-associated renal disease.
- Wolmans disease
- Kearns–Sayre syndrome
- Smith–Lemli–Opitz syndrome
- Sitosterolemia (also known as phytoster-olemia)
References
- ↑ Liamis G, Liberopoulos E, Barkas F, Elisaf M (2014). "Diabetes mellitus and electrolyte disorders". World J Clin Cases. 2 (10): 488–96. doi:10.12998/wjcc.v2.i10.488. PMC 4198400. PMID 25325058.
- ↑ Uribarri J, Oh MS, Carroll HJ (1990). "Hyperkalemia in diabetes mellitus". J Diabet Complications. 4 (1): 3–7. PMID 2141843.
- ↑ Bojestig M, Nystrom FH, Arnqvist HJ, Ludvigsson J, Karlberg BE (2000). "The renin-angiotensin-aldosterone system is suppressed in adults with Type 1 diabetes". J Renin Angiotensin Aldosterone Syst. 1 (4): 353–6. doi:10.3317/jraas.2000.065. PMID 11967822.
- ↑ Shaked Y, Blau A, Shpilberg O, Samra Y (1993). "Hyporeninemic hypoaldosteronism associated with multiple myeloma: 11 years of follow-up". Clin. Nephrol. 40 (2): 79–82. PMID 8222376.